Cargando…
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin
The implications of these findings are significant for development of CXCR2 antagonists and other mechanisms targeting neutrophil activation or NETosis, suggesting that IL-8-dependent mechanisms will only work in a subset of COPD patients https://bit.ly/32SeisO
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682717/ https://www.ncbi.nlm.nih.gov/pubmed/33263062 http://dx.doi.org/10.1183/23120541.00583-2020 |
_version_ | 1783612735885410304 |
---|---|
author | Keir, Holly R. Richardson, Hollian Fillmore, Christina Shoemark, Amelia Lazaar, Aili L. Miller, Bruce E. Tal-Singer, Ruth Chalmers, James D. Mohan, Divya |
author_facet | Keir, Holly R. Richardson, Hollian Fillmore, Christina Shoemark, Amelia Lazaar, Aili L. Miller, Bruce E. Tal-Singer, Ruth Chalmers, James D. Mohan, Divya |
author_sort | Keir, Holly R. |
collection | PubMed |
description | The implications of these findings are significant for development of CXCR2 antagonists and other mechanisms targeting neutrophil activation or NETosis, suggesting that IL-8-dependent mechanisms will only work in a subset of COPD patients https://bit.ly/32SeisO |
format | Online Article Text |
id | pubmed-7682717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-76827172020-11-30 CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin Keir, Holly R. Richardson, Hollian Fillmore, Christina Shoemark, Amelia Lazaar, Aili L. Miller, Bruce E. Tal-Singer, Ruth Chalmers, James D. Mohan, Divya ERJ Open Res Original Research Letters The implications of these findings are significant for development of CXCR2 antagonists and other mechanisms targeting neutrophil activation or NETosis, suggesting that IL-8-dependent mechanisms will only work in a subset of COPD patients https://bit.ly/32SeisO European Respiratory Society 2020-11-10 /pmc/articles/PMC7682717/ /pubmed/33263062 http://dx.doi.org/10.1183/23120541.00583-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Original Research Letters Keir, Holly R. Richardson, Hollian Fillmore, Christina Shoemark, Amelia Lazaar, Aili L. Miller, Bruce E. Tal-Singer, Ruth Chalmers, James D. Mohan, Divya CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin |
title | CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin |
title_full | CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin |
title_fullStr | CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin |
title_full_unstemmed | CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin |
title_short | CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin |
title_sort | cxcl-8-dependent and -independent neutrophil activation in copd: experiences from a pilot study of the cxcr2 antagonist danirixin |
topic | Original Research Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682717/ https://www.ncbi.nlm.nih.gov/pubmed/33263062 http://dx.doi.org/10.1183/23120541.00583-2020 |
work_keys_str_mv | AT keirhollyr cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT richardsonhollian cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT fillmorechristina cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT shoemarkamelia cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT lazaarailil cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT millerbrucee cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT talsingerruth cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT chalmersjamesd cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin AT mohandivya cxcl8dependentandindependentneutrophilactivationincopdexperiencesfromapilotstudyofthecxcr2antagonistdanirixin |